Back

Monocytes Strongly Induce (Myo)Fibroblast Contraction In A New 3D Skin Model To Understand The Inflammation-Fibrosis Axis In Systemic Sclerosis

Zanin-Silva, D. C.; van Kooten, N. J. T.; Papadimitriou, T. I.; Dorst, D. N.; Walgreen, B.; Vitters, E.; van den Bosch, M. H. J.; Koenders, M. I.; van Caam, A. P. M.

2026-02-14 immunology
10.64898/2026.02.12.705496 bioRxiv
Show abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by excessive fibrosis and tissue stiffness, in which monocytes and macrophages are increasingly recognized as key contributors to pro-fibrotic myofibroblast formation and activation, although the underlying mechanisms remain incompletely understood. Here, we used a three-dimensional (3D) skin model to study how CD14+ monocytes, M1 and M2-like macrophages induce (myo)fibroblasts activation/contraction in collagen type I hydrogels. We identified that co-culture of fibroblasts with monocytes displayed strong spontaneous hydrogel contraction, coupled with an upregulation of myofibroblasts activation-associated markers, such as -SMA and fibroblast activation protein. Using transcription-factor reporter constructs and small molecules inhibitors, we demonstrated that monocyte-fibroblast communication was mediated by JAK/STAT3 and TGF-{beta}/Smad2/3 signaling pathways. Flow cytometry analyses revealed that monocytes, after interacting with fibroblasts, differentiated into a mixed M1/M2 polarization phenotype, characterized by CD163, CD206, CD86, and HLA-DR expression. Both M1 and M2-like macrophages promoted significant myofibroblast contraction, which could be mimicked by supernatant transfer. TGF-{beta} neutralization but not IL-6 blocking abolished this effect. This study demonstrates that monocytes/macrophages can strongly induce (myo)fibroblasts activation/contraction. Together, our work contributes to elucidating pathways and mechanisms associated with skin fibrosis in SSc and paves the way for developing new platforms for targeted therapy testing.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Arthritis & Rheumatology
33 papers in training set
Top 0.1%
23.9%
2
Journal of Investigative Dermatology
42 papers in training set
Top 0.1%
7.6%
3
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.1%
7.2%
4
Frontiers in Immunology
586 papers in training set
Top 2%
3.9%
5
Scientific Reports
3102 papers in training set
Top 33%
3.8%
6
Arthritis Research & Therapy
15 papers in training set
Top 0.1%
3.8%
50% of probability mass above
7
JCI Insight
241 papers in training set
Top 3%
2.0%
8
eLife
5422 papers in training set
Top 38%
1.9%
9
Advanced Science
249 papers in training set
Top 10%
1.8%
10
Stem Cell Research & Therapy
30 papers in training set
Top 0.3%
1.8%
11
iScience
1063 papers in training set
Top 13%
1.8%
12
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 5%
1.6%
13
The FASEB Journal
175 papers in training set
Top 1%
1.4%
14
Molecular Therapy
71 papers in training set
Top 2%
1.4%
15
European Journal of Immunology
57 papers in training set
Top 0.3%
1.4%
16
PLOS ONE
4510 papers in training set
Top 63%
0.9%
17
European Respiratory Journal
54 papers in training set
Top 1%
0.9%
18
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.6%
0.9%
19
Matrix Biology
28 papers in training set
Top 0.2%
0.9%
20
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.8%
21
International Journal of Molecular Sciences
453 papers in training set
Top 14%
0.8%
22
RMD Open
13 papers in training set
Top 0.3%
0.8%
23
Journal of Biomedical Materials Research Part A
18 papers in training set
Top 0.4%
0.8%
24
Computational and Structural Biotechnology Journal
216 papers in training set
Top 8%
0.8%
25
Clinical Immunology
21 papers in training set
Top 0.6%
0.8%
26
Journal of Advanced Research
15 papers in training set
Top 0.7%
0.8%
27
Aging Cell
144 papers in training set
Top 4%
0.7%
28
Journal of Translational Medicine
46 papers in training set
Top 3%
0.7%
29
Theranostics
33 papers in training set
Top 2%
0.7%
30
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 0.9%
0.7%